DCPH - Deciphera Pharmaceuticals Inc. (DCPH) CEO Steve Hoerter on Q3 2021 Results - Earnings Call Transcript

Start Time: 16:30 End Time: 17:30 Deciphera Pharmaceuticals, Inc. (DCPH) Q3 2021 Earnings Conference Call November 02, 2021, 16:30 PM ET Company Participants Steve Hoerter - President and CEO Dan Martin - Chief Commercial Officer Matt Sherman - Chief Medical Officer Tucker Kelly - CFO Jen Robinson - VP, IR Conference Call Participants Chris Raymond - Piper Sandler Jessica Fye - JPMorgan Paul Jeng - Guggenheim Eun Yang - Jefferies Reni Benjamin - JMP Securities Bradley Canino - Stifel Presentation Operator Good afternoon, everyone, and welcome to the Deciphera Pharmaceuticals Third Quarter 2021 Financial Results Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Jen Robinson, Vice President of Investor Relations. Jen? Jen Robinson Thank you, operator. Welcome, and thank you for joining us today to discuss Deciphera's third quarter 2021 financial results. I'm Jen Robinson, Vice President, Investor Relations

For further details see:

Deciphera Pharmaceuticals, Inc. (DCPH) CEO Steve Hoerter on Q3 2021 Results - Earnings Call Transcript